House of Assembly Fifty-Second Parliament, Second Session (52-2) 52 2 Parliament of South Australia House of Assembly published Answers to Questions Answers to Questions Institute of Medical and Veterinary Science INSTITUTE OF MEDICAL AND VETERINARY SCIENCE Dr McFETRIDGE House of Assembly Morphett INSTITUTE OF MEDICAL AND VETERINARY SCIENCE 230 Dr McFETRIDGE (Morphett) (15 March 2011) (First Session). 1.	What plans does the Government have for the future use of heritage listed buildings currently used by the IMVS and what is the budget for the implementation of these plans? 2.	What are the results of the amalgamation of Government pathology services and what is the current market share held by IMVS? 3.	How many IMVS research projects have been commercialised in each year since 2000? The Hon. J.D. HILL House of Assembly Kaurna Minister for Health and Ageing Minister for Mental Health and Substance Abuse Minister for the Arts INSTITUTE OF MEDICAL AND VETERINARY SCIENCE The Hon. J.D. HILL (Kaurna—Minister for Health and Ageing, Minister for Mental Health and Substance Abuse, Minister for the Arts): I am advised: 1.	The future use of heritage buildings on the existing Royal Adelaide Hospital (RAH) site (including those currently used by IMVS) will be considered further as part of a master planning process to be undertaken to determine the best use of the current RAH site, once the majority of services relocate to the new RAH. Determination of funding mechanisms for any such development will form part of that planning process. 2.	Since the formation of SA Pathology, staff numbers and services have expanded. SA Pathology has now taken over the provision of pathology services at Modbury Hospital, as well as increased clinical services in haematology at Lyell McEwin Hospital and genetic medicine at the current RAH. SA Pathology increased its market share in South Australia from 32.94 per cent in June 2008 to 37.51 per cent in June 2011. This added over $20 million to Government revenue at the same time as delivering efficiencies of over $7 million per annum since 2008. 3.	The following table shows the number of IMVS projects commercialised in each year since 2000 to June 2011: Year No. of Patents Commercialised 2000 16 2001 38 2002 51 2003 22 2004 40 2005 58 2006 39 2007 49 2008 14 2009 17 2010 10 To June 2011 0 Total 354